Abstract
Introduction
Iron homeostasis depends on a complex mechanism on the principle of feedback between the needs of the human body for iron and intestinal absorption. There is no physiological mechanism for the excretion of excess iron. The hepcidin hormone, discovered in 2001, is now considered to be the key regulator of iron homeostasis. The impaired regulation of hepcidin is the reason for many of the iron homeostasis disorders [1] , [2] .
In healthy persons, iron absorption, transport and storage are strictly controlled processes due to the lack of a physiological pathway for the excretion of excess iron from the body. The liver, the duodenum and the bone marrow are involved in the control of iron metabolism. Healthy elderly people have approx. 4 grams of iron in their bodies, about 3 grams of which are used to synthesize hemoglobin in the erythrocytes. When the erythrocytes get mature and die, their hemoglobin breaks down into its constituent parts-heme and globin. The heme-free iron is transferred from the transferrin to return to the heme synthesis cycle for erythropoiesis. These facts show that in a completely healthy adult, the body re-uses most of the available iron. Just 1 mg of iron is discharged from the body on a daily basis, mainly through the urine, faeces, enterocyte and epidermal desquamation in men, and through menstruation in women. Discharged iron is replaced by iron absorbed by the gastrointestinal tract through the food.
Material and Methods

Material
Subject to the testing were 60 healthy volunteers involved in clinical trials None of them had any medical history, physical, laboratory, serological (HIV, HBV, HCV and acute HAV infection) testing as well as ECG and ultrasound data for current or past liver and gallbladder diseases, anemia, diabetes mellitus, cardiovascular, renal and other significant diseases, pregnancy, medication and toxic substance intake, including absolute alcohol over 20g daily, and any other conditions that could affect the results.
Methods
1.
Case histories, physical check-up and demographic data.
2. Standard and specific disease-excluding laboratory blood and urine tests, immunological and virological studies. 
Results
In none of the healthy persons we observed any deviation in the serum markers of iron metabolism tested from the reference values with the exception of hepcidin. Twelve of the investigated persons (20%) showed hepcidin below the lower reference value.
The mean values for the iron metabolism variables are given in Table 2 .
The serum iron levels in healthy persons showed a positive correlation with IBC (Pearson correlation, r = 0.303, p = 0.019). There was also a reciprocal correlation between the serum hepcidin levels and transferrin saturation (Pearson correlation r = -0.675, p = 0.0001). Relation of serum iron metabolism variables to sex, age and BMI
In the group of healthy persons, we identified that the serum iron, IBC and ferritin values were considerably higher with men than those with women ( Table 3 ) and also that there was no significant differences in transferrin saturation (p = 0.143) and hepidine (p = 0.228) between both sexes. We identified no difference in the serum markers of iron metabolism of people under 45 years of age and those over 45 years old (Table 4) . Furthermore, we could not prove any relation based on age. The average BMI value for the group of healthy persons was 23.01 ± 2.54 (ranging between 19.5 and 29.70), 50 (83%) of whom had normal body weight (BMI < 25) and the remaining 10 were overweight (BMI > 25 and < 30). No significant relation was identified between BMI and the serum iron metabolism variables (Table 5 ). 
Discussion
In recent years, there has been an increased interest in the conditions and diseases accompanied by higher iron status and their evolution. Currently there are no sufficient comparative data available on the incidence and the characteristics of such disorders in people with chronic liver diseases compared to healthy people. For this purpose, we studied the serum iron metabolism in 60 healthy persons.
Iron is essential for a number of key biological processes including erythrocyte production, DNA synthesis and cellular respiration [3] , [5] , [6] . The normal iron content in the body of an adult man is 35-45 mg. iron per kilogram of body weight [3] . Most of the iron is combined with hemoglobin in the erythrocytes. The rest is distributed in the myoglobin in the muscles, in the tissue enzymes and the plasma transferin [3] . The liver parenchymal cells and the reticuloendothelial macrophages serve as a depot for storage of excess iron [3] , [7] . In connection with its potential to take part in reactions as a transition metal, iron can be toxic in the cell [7] , [1] . Iron-mediated generation of highly toxic Reactive Oxygen Species (ROS) plays a major role in the process leading to iron overload-related diseases [8] .
Since there is no physiological pathway for the removal of excess iron from the body, iron acquisition, metabolism and storage must be strictly regulated [2] , [6] , [9] . A large number of new ironregulating molecules, including iron transporters and soluble mediators, have been identified in recent years. Divalent Metal Transporter-1 (DMT1, also known as Nramp2) is a multifunctional transmembrane protein [4] , [10] , [11] responsible for the passage of non-food iron through the apical surface of the absorbing enterocytes in the duodenum. Ferroportin (also known as MTP1, Ireg1) transports iron into the blood. As a portable metal, iron undergoes reduction and oxidation reactions during this cell intake [7] , [11] . Iron circulates in the plasma by binding to glyco protein, transferrin (Tf). The iron delivering Tf is absorbed by the cell to form compounds with transferrin receptor 1, TrfR [3] , [7] , [10] .
Regulation of the iron metabolism involves many organs -the duodenum, the liver, the bone marrow. The identification of hepcidin-peptide emphasizes the importance of the liver in iron homeostasis. Hepcidin is an antimicrobial peptide that is isolated from human urine and blood [3] , [6] . It is synthesized in the liver hepatocytes. Hepcidin synthesis in the liver is sensitive to iron levels-it increases in the presence of excessive iron and decreases in cases of iron deficiency [12] , [13] , [14] .
Interestingly, the synthesis of hepcidin is also regulated by inflammatory signals and by the inflammatory cytokines IL-1 and IL-6 [1] , [15] . The role of the Kupffer cells in the regulation of hepcidin levels in inflammation is disputable.
Hepcidin plays a major role in iron metabolism by inhibiting intestinal iron metabolism and iron release by the macrophages [7] , by binding to ferroportin and inducing cellular penetration and degradation [15] .
In conclusion, a better understanding of the molecular mechanisms that regulate the iron homeostasis can help develop therapeutic strategies and diagnostic methods for the detection of liver diseases in their early stages before they could turn into chronic diseases and cause irreversible liver damage.
In healthy persons there is only a positive correlation between iron level and IBC, and feedback between hepcidin serum levels and transferrin saturation.
